Research Article

Effectiveness of Second through Sixth Line Salvage Helicobacter pylori Treatment: Bismuth Quadruple Therapy is Almost Always a Reasonable Choice

Figure 7

Eradication with bismuth quadruple therapy based on previous exposure to a metronidazole-containing H. pylori treatment. Risk difference: 10% (PP, 95% CI: −2–25) and 8% (ITT, 95% CI: −5–25).